Arthritis Rheum. 1997 May;40(5):842-8.

Treatment of early rheumatoid arthritis with minocycline or placebo: results of a randomized, double-blind, placebo-controlled trial.

O'Dell JR, Haire CE, Palmer W, Drymalski W, Wees S, Blakely K, Churchill M, Eckhoff PJ, Weaver A, Doud D, Erikson N, Dietz F, Olson R, Maloley P, Klassen LW, Moore GF.

Source

University of Nebraska Medical Center and Omaha VA Hospital, 68198-3025, USA.

Abstract

OBJECTIVE:

To determine if minocycline is an effective therapy for seropositive rheumatoid arthritis (RA) when used within the first year of disease.

METHODS:

The Rheumatoid Arthritis Investigational Network enrolled 46 patients with RA of <1 year duration into a 6-month study of minocycline (100 mg twice daily) versus placebo. All patients were rheumatoid factor positive. The primary end point of the study was successful completion of 6 months of treatment with no drug toxicity while maintaining 50% improvement in composite symptoms of arthritis.

RESULTS:

Eighteen of the 46 patients who were enrolled met 50% improvement criteria at 3 months, and maintained at least a 50% improvement for 6 months with no significant drug toxicity. Among them were 15 of the 23 patients (65%) treated with minocycline and 3 of 23 patients (13%) treated with placebo (P < 0.001).

CONCLUSION:

In patients with early seropositive RA, therapy with minocycline is superior to placebo.

Comment in

Arthritis Rheum. 1997 May;40(5):794-6.

PMID:: 9153544; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Ovid Technologies, Inc.

Medical

Molecular Biology Databases

MINOCYCLINE - HSDB

Supplemental Content

Related citations

Treatment of early seropositive rheumatoid arthritis with minocycline: four-year followup of a double-blind, placebo-controlled trial. [Arthritis Rheum. 1999]
Treatment of early seropositive rheumatoid arthritis with minocycline: four-year followup of a double-blind, placebo-controlled trial.
O'Dell JR, Paulsen G, Haire CE, Blakely K, Palmer W, Wees S, Eckhoff PJ, Klassen LW, Churchill M, Doud D, et al. Arthritis Rheum. 1999 Aug; 42(8):1691-5.
Minocycline in active rheumatoid arthritis. A double-blind, placebo-controlled trial. [Arthritis Rheum. 1994]
Minocycline in active rheumatoid arthritis. A double-blind, placebo-controlled trial.
Kloppenburg M, Breedveld FC, Terwiel JP, Mallee C, Dijkmans BA. Arthritis Rheum. 1994 May; 37(5):629-36.
Minocycline in rheumatoid arthritis. A 48-week, double-blind, placebo-controlled trial. MIRA Trial Group. [Ann Intern Med. 1995]
Minocycline in rheumatoid arthritis. A 48-week, double-blind, placebo-controlled trial. MIRA Trial Group.
Tilley BC, Alarcón GS, Heyse SP, Trentham DE, Neuner R, Kaplan DA, Clegg DO, Leisen JC, Buckley L, Cooper SM, et al. Ann Intern Med. 1995 Jan 15; 122(2):81-9.
Review Benefits and risks of minocycline in rheumatoid arthritis. [Drug Saf. 2000]
Review Benefits and risks of minocycline in rheumatoid arthritis.
Langevitz P, Livneh A, Bank I, Pras M. Drug Saf. 2000 May; 22(5):405-14.
Review Etanercept: a review of its use in rheumatoid arthritis. [Drugs. 1999]
Review Etanercept: a review of its use in rheumatoid arthritis.
Jarvis B, Faulds D. Drugs. 1999 Jun; 57(6):945-66.

See reviews... See all...

Cited by 7 PubMed Central articles

Randomised double-blind trial of combination antibiotic therapy in rheumatoid arthritis. [Int J Rheumatol. 2011]
Randomised double-blind trial of combination antibiotic therapy in rheumatoid arthritis.
Smith A, Doré C, Charles P, Vallance A, Potier T, Mackworth-Young C. Int J Rheumatol. 2011; 2011:585497. Epub 2011 Jul 6.
Review Bacterial and human peptidylarginine deiminases: targets for inhibiting the autoimmune response in rheumatoid arthritis? [Arthritis Res Ther. 2010]
Review Bacterial and human peptidylarginine deiminases: targets for inhibiting the autoimmune response in rheumatoid arthritis?
Mangat P, Wegner N, Venables PJ, Potempa J. Arthritis Res Ther. 2010; 12(3):209. Epub 2010 Jun 2.
Antibody responses to Porphyromonas gingivalis (P. gingivalis) in subjects with rheumatoid arthritis and periodontitis. [Int Immunopharmacol. 2009]
Antibody responses to Porphyromonas gingivalis (P. gingivalis) in subjects with rheumatoid arthritis and periodontitis.
Mikuls TR, Payne JB, Reinhardt RA, Thiele GM, Maziarz E, Cannella AC, Holers VM, Kuhn KA, O'Dell JR. Int Immunopharmacol. 2009 Jan; 9(1):38-42. Epub 2008 Oct 9.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Treatment of early rheumatoid arthritis with minocycline or placebo: results of ...
Treatment of early rheumatoid arthritis with minocycline or placebo: results of a randomized, double-blind, placebo-controlled trial.
Arthritis Rheum. 1997 May ;40(5):842-8.

PubMed
Disinsertion of the aponeurosis of the levator palpebrae superioris muscle after...
Disinsertion of the aponeurosis of the levator palpebrae superioris muscle after cataract extraction.
Am J Ophthalmol. 1976 Mar ;81(3):337-40.

PubMed
Electrophysiological correlates and neural substrates of alimentary behavior in ...
Electrophysiological correlates and neural substrates of alimentary behavior in the cat.
Ann N Y Acad Sci. 1969 May 15 ;157(2):723-39.

PubMed
Characterization of long terminal repeat sequences of HTLV-III.
Characterization of long terminal repeat sequences of HTLV-III.
Science. 1985 Feb 1 ;227(4686):538-40.

PubMed
Otoneurological observation and classification of Harada's disease presenting wi...
Otoneurological observation and classification of Harada's disease presenting with aural symptoms, especially vertigo.
Acta Otolaryngol Suppl. 1995 ;519:114-7.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Display Settings:

Send to: